[GET] Pharmaceutical Clinical Bioequivalence Study (BA/BE)

[mindpower]

Pharmaceutical Clinical Bioequivalence Study (BA/BE)
Clinical Bioequivalence Study, BABE, Types of Study designs, Crossover Design, Parallel Design, AUC, Cmax, Tmax, PK/PD
Rating: 3.9 out of 5
(18 ratings)
1,423 students
2 hours on-demand video
5 downloadable resources

Description
Bioequivalence studies are very important for the development of a pharmaceutical preparation in the pharmaceutical industry. Their rationale is the monitoring of pharmacokinetic and pharmacodynamic parameters after the administration of tested drugs.

Note: If you are paying more than 5k INR or $15 for private institute/academy then you are in loss.

Please compare the course description and amount you are paying for such course.

Bioavailability and Bioequivalence

Bioavailability (BA) is defined as the rate and extent to which the unchanged active substance is absorbed and becomes available in the systemic circulation. Understanding bioavailability is essential during drug development as it is one of the fundamental properties of drug formulation.

Information on bioavailability is also used to determine bioequivalence (BE) when submitting a generic dossier.

Through interactive sessions and multiple case studies, this course will evaluate every aspect of BA/BE from the regulations and types of protocol studies to bioanalysis, statistical analysis and reporting. Once completed you will have a solid understanding of bioavailability, supporting you in drug development.

You will also have the confidence to develop and implement your own bioequivalence studies to ensure speedy generic approval.

The course will also examine key aspects of biowaivers such as the regulatory hurdles, types of biowaivers and data needed so you can save money and time with fast biowaiver applications.

https://www.udemy.com/course/pharmaceutical-bioavailabilitybioequivalence-study-babe/?couponCode=GOODREVIEWONLY

Enjoy!